KD Logo

Replimune Group Inc (REPL) receives an Overweight rating from Piper Sandler

In a filing, Replimune Group Inc revealed its Chief Medical Officer Xynos Konstantinos unloaded Company’s shares for reported $79858.0 on Nov 16 ’23. In the deal valued at $10.92 per share,7,313 shares were sold. As a result of this transaction, Xynos Konstantinos now holds 112,714 shares worth roughly $0.72 million.

Then, Sarchi Christopher sold 5,255 shares, generating $57,385 in total proceeds. Upon selling the shares at $10.92, the Chief Commercial Officer now owns 72,245 shares.

Before that, Esposito Pamela sold 300 shares. Replimune Group Inc shares valued at $6,000 were divested by the Chief Business Officer at a price of $20.00 per share. As a result of the transaction, Esposito Pamela now holds 263,436 shares, worth roughly $1.67 million.

A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid November with a ‘”an Overweight”‘ rating. BTIG Research started covering the stock on November 17, 2020. It rated REPL as “a Buy”.

Price Performance Review of REPL

On Tuesday, Replimune Group Inc [NASDAQ:REPL] saw its stock fall -3.50% to $6.35. Over the last five days, the stock has lost -1.09%. Replimune Group Inc shares have fallen nearly -24.67% since the year began. Nevertheless, the stocks have fallen -62.04% over the past one year. While a 52-week high of $24.81 was reached on 01/10/24, a 52-week low of $5.86 was recorded on 04/25/24. SMA at 50 days reached $7.77, while 200 days put it at $12.15. A total of 0.46 million shares were traded, compared to the trading of 0.48 million shares in the previous session.

Levels Of Support And Resistance For REPL Stock

The 24-hour chart illustrates a support level at 6.26, which if violated will result in even more drops to 6.17. On the upside, there is a resistance level at 6.53. A further resistance level may holdings at 6.71. The Relative Strength Index (RSI) on the 14-day chart is 35.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.79%. Stochastics %K at 37.58% indicates the stock is a holding.

The most recent change occurred on November 02, 2020 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $67 price target.

Most Popular

[the_ad id="945"]